BIOCOM for BIOCOM
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Advocated in favor of the USMCA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Taxation/Internal Revenue Code TAX
Advocated to permanently repeal the medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Copyright/Patent/Trademark CPT
Opposed legislation and policies that would undermine the US patent system, including "compulsory licenses"
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Budget/Appropriations BUD
Advocated for additional funding for NIH and FDA in FY2020 appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Advocated against HR3, the Lower Drug Costs Now Act of 2019, because of the negative impact it would have on innovation. Hosted a congressional briefing on Precision Medicine. Hosted a legislative roundtable with Rep. Eric Swalwell.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.